Mayo LM
Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, AB, Canada.
ArticlePsychedelics
A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations.
ArticlePsychedelics
Exploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions.
ArticleMDMA
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.
ArticleMDMA
The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults.
ArticlePsilocybin
Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.
ArticlePsilocybin
Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review.
ArticlePsilocybin
Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.
ArticlePsilocybin
Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.
ArticlePsilocybin
Impact of psilocybin on cognitive function: A systematic review.
ArticleIbogaine
Tripping outside the lines: lessons from observational studies of combination psychedelic use beyond regulated clinical contexts.
ArticleMDMA